Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

A smartphone application for muscle relaxation significantly reduces migraine-related disability in patients visiting the ...

A large study suggests taking progesterone before pregnancy — not just after conception — may help reduce the risk for ...

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...

General anesthesia leads to better functional outcomes than conscious sedation in stroke patients with large vessel occlusion ...

A spectrum labeling system rating foods from least to most healthy can promote healthier food purchases than other ...

The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...

The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who ...

Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...

Although widely prescribed off-label to treat many types of chronic pain, experts warn of harmful side effects.